Findings provide further evidence of overall survival benefit of TEVIMBRA plus ZIIHERA and chemotherapy regimen in HER2+ GEA ZIIHERA plus chemotherapy demonstrated statistically significant overall survival benefit at second interim analysis of HERIZON-GEA-01 trial SAN CARLOS, Calif. — BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced…
A new study reveals that two different inflammatory proteins in the blood signal separate types of brain damage. Both distinct pathways ultimately converge to fuel Alzheimer's-related tau tangles…
Shivamogga sub-division Assistant Commissioner Maitri H.P.S. instructed the owners and managers that food-handling staff should undergo periodic health check-up, and receive the necessary training in safe food-handling practices
